Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Uterine Cervical Neoplasms 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neuritis 1Neoplasms 1Neoplasm Metastasis 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Esthesioneuroblastoma, Olfactory 1Colorectal Neoplasms 1Colonic Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Trastuzumab 351Paclitaxel 334Cyclophosphamide 315Docetaxel 292Capecitabine 181Doxorubicin 180Letrozole 165Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 83Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 68Filgrastim 64Albumin-Bound Paclitaxel 64Magnetic Resonance Spectroscopy 56eribulin 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Diffusion Tensor Imaging × Clear all
NCT02812589 2021-04-13

Diffusion Tensor Breast MRI (DTI)

University Health Network, Toronto

Phase NA Completed
267 enrolled
Breast

Breast Neoplasms

NCT03365895 2020-11-19

CIPN

University of Arizona

Phase NA Completed
17 enrolled
Breast

Breast Neoplasms, Neuritis, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡